Analysts have a consensus target price of $ 51.82 in the 12-month period. The price objective is 6.67% higher than the recent closing price of $ 48.58. The 52-week price range is $ 39.50 – 54.44 and the company has a market capitalization of $ 5.43B. Analysts covering the shares maintain a consensus Buy rating, according to Zacks Investment Research. 1 analyst has rated the stock with a sell rating, 7 has assigned a hold rating, 1 says it’s a buy, and 6 have assigned a strong buy rating to the company.
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerate the discovery and development of critical new therapies. It provides early detection for genetic disorders from pregnancy to early childhood, as well as flat panel X-ray detectors and infectious disease testing for the diagnostics market; and a suite of solutions, including reagents, liquid handling systems, and detection and imaging technologies that enable scientists to enhance life sciences research and drug discovery processes. This segment’s research portfolio includes instrumentation for automation and detection solutions, and in vitro and ex vivo, as well as in vivo imaging and analysis hardware and software; and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides products, services, and solutions to facilitate the creation of safer food and consumer products. It develops and provides analytical technologies, solutions, and services that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. This segment also provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, food, lubricant, petrochemical, and polymer industries; and laboratory services. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.
0 yorum:
Yorum Gönder